Growth Metrics

Clorox (CLX) Common Equity (2016 - 2025)

Clorox has reported Common Equity over the past 17 years, most recently at -$125.0 million for Q4 2025.

  • Quarterly results put Common Equity at -$125.0 million for Q4 2025, down 203.31% from a year ago — trailing twelve months through Dec 2025 was -$125.0 million (down 203.31% YoY), and the annual figure for FY2025 was $321.0 million, down 34.76%.
  • Common Equity for Q4 2025 was -$125.0 million at Clorox, down from $138.0 million in the prior quarter.
  • Over the last five years, Common Equity for CLX hit a ceiling of $938.0 million in Q1 2021 and a floor of -$125.0 million in Q4 2025.
  • Median Common Equity over the past 5 years was $354.5 million (2023), compared with a mean of $361.1 million.
  • Biggest five-year swings in Common Equity: surged 70.99% in 2024 and later crashed 203.31% in 2025.
  • Clorox's Common Equity stood at $491.0 million in 2021, then changed by 0.0% to $491.0 million in 2022, then plummeted by 55.6% to $218.0 million in 2023, then tumbled by 44.5% to $121.0 million in 2024, then crashed by 203.31% to -$125.0 million in 2025.
  • The last three reported values for Common Equity were -$125.0 million (Q4 2025), $138.0 million (Q3 2025), and $321.0 million (Q2 2025) per Business Quant data.